Wanli Wu
Wanli Wu practices in all aspects of patent law with a focus on chemistry and material science related inventions. Wanli has more than 15 years of experience drafting patent applications and obtaining worldwide patents in the fields of small molecules, medical therapeutics, polymers, oil and gas field fluids and applications, hydrocarbon recovery and treatment, batteries, CO2 capture, cosmetics, and specialty chemicals. She has also conducted patentability, product clearance, and patent validity studies and has experience in IP transactions. Prior to becoming a patent lawyer, Ms. Wu was a research chemist for eight years for two global pharmaceutical companies. During that time, she synthesized novel Hepatitis C drug candidates and was an inventor for several patents/applications.
Comiskey Revisted: Section 101 as Gatekeeper for Patentability Requirements?
Presenter, 25th Annual Joint Patent Practice Seminar, April 30, 2009
Novel inhibitors of hepatitis C NS3-NS4A serine protease derived from 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid
Bioorganic & Medicinal Chemistry Letters, Volume 16, Issue 6, pages 1628-1632, 2006
Rutgers School of Law
University of Mississippi
-
Graduate School Honor Fellowship (1996-99)
Nankai University
-
Graduate School Merit Scholarship (1995)
Nankai University
-
Academic Honors (1992)
Prior to joining Stites & Harbison, Wanli worked as a patent attorney for a full-service law firm and a large IP law firm, representing startups, research institutes, and global companies.
Before entering the legal field, she had eight years of research experience as a medicinal chemist for two global pharmaceutical companies. She received the New Jersey Thomas A. Edison Patent Award, the Schering Plough Presidential Award, and the Shinning Performance Award for her research on hepatitis C virus protease inhibitors.
In May 2017, she was a voluntary judge for the National Mock Trial. From 2012-13, she was a member of NYIPLA Board of Directors.
Mandarin Chinese